Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Multicenter, Real-World Experience Study of FLT3-Inhibitor Post-Transplant Maintenance Therapy Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia with FLT3-ITD

Yomna Eissa, Hyeoung-Joon Kim, Joon Ho Moon, Robert Zeiser, Francesca Biavasco, Christopher Lemieux, Mohamed Elemary, Varun Mehra, Mili Shah, Ahmed Alotaibi, Yu Cai, Xianmin Song, Jae-Sook Ahn, Sang Kyun Sohn, Mohsen Al Zahrani, Muhned Alhumaid, Hee-Je Kim, Dennis Dong Hwan Kim

Blood (2024) 144 (Supplement 1): 778.

https://doi.org/10.1182/blood-2024-208622

Published: 2024

Journal Articles

Comparison of Riete and Some Scores for Predicting Cancer in Unprovoked Thrombosis

Abdulrahman Al Raizah, Mohammed Ziyadah, Abdulaziz Alahmary, Nahla Wahby, Albarra Madkhali, Abdullah S. Al Saleh, Mohsen Al Zahrani, Aymen Hejazi, Ahmed Alaskar

Blood (2024) 144 (Supplement 1): 2627.

https://doi.org/10.1182/blood-2024-204655

Published: 2024

Journal Articles

Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy?

Blood (2024) 144 (Supplement 1): 7418.

https://doi.org/10.1182/blood-2024-206153

Published: 2024

Journal Articles

Allogeneic Transplantation for Sickle Cell Disease Offers High Rates of Cure with Low Incidence of Severe Chronic GVHD in Both Children and Adults: Real World Data from 2010-2021. An Analysis of the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Working Party

Blood (2024) 144 (Supplement 1): 176.

https://doi.org/10.1182/blood-2024-207944

Published: 2024

Journal Articles

A Novel Score for Prediction of Cancer in Unprovoked Venous Thromboembolism

Abdulrahman Al Raizah, Mohammed Ziyadah, Abdulaziz Alahmary, Nahla Wahby, Albarra Madkhali, Mohsen Al Zahrani, Aymen Hejazi, Ahmed Alaskar, Mshabab Alrizah

Blood (2024) 144 (Supplement 1): 5566.

https://doi.org/10.1182/blood-2024-206705

Published: 2024

Journal Articles

Significant Growth in HCT Use for Haemoglobinopathies in the Last Decade Driven By Sickle Cell Disease across All Ages with Excellent Outcomes: An Analysis of EBMT Haemoglobinopathies Working Party

Blood (2024) 144 (Supplement 1): 2184.

https://doi.org/10.1182/blood-2024-208191

Published: 2024

Journal Articles

Role of Age and Donor Type in 3646 Severe Aplastic Anemia Patients Undergoing Hematopoietic Stem Cell Transplantation in 2011-2020: A Retrospective EBMT-Saawp Study

Blood (2024) 144 (Supplement 1): 595.

https://doi.org/10.1182/blood-2024-194713

Published: 2024

Journal Articles

Multicenter Retrospective Analysis on the Clinical Benefit of Post-Transplant Tyrosine Kinase Inhibitor (TKI) Maintenance Therapy in Ph-Positive Acute Lymphoblastic Leukemia Suggests Improved GvHD-Free, Relapse Free Survival and Non-Relapse Mortality, but Not the Risk of Relapse

Eshrak Al-Shaibani, Yu Cai, Xianmin Song, Mohsen Al Zahrani, Mohamed Elemary, Muhned Alhumaid, Hanan Alkhaldi, Ayman Saad, Francesca Biavasco, Robert Zeiser, Joon Ho Moon, Sang Kyun Sohn, Jonas Mattsson, Dennis Dong Hwan Kim

Blood (2024) 144 (Supplement 1): 4930.

https://doi.org/10.1182/blood-2024-211761

Published: 2024

Journal Articles

Non-Myeloablative Transplant in Severe Sickle Cell Disease Is Safe & Effective. Single Center Experience from Saudi Arabia

Mohsen Al-Zahrani, MD, Ahmed Alaskar, MD FRCPC, Moussab Damlaj, MD, Khadega Abuelgasim, MD, Giamal Gmati, MD, Hind ABDIN Salama, MD, Samer Ghazi, Osama Ali, MD, Bader Alahmari, MD, Ayman Hejazi, MD

Blood (2017) 130 (Supplement 1): 5549.

https://doi.org/10.1182/blood.V130.Suppl_1.5549.5549

Published: 2017

Journal Articles

Escalation from ABVD Following Positive Interim Functional Imaging Improves Progression Free Survival but Not Overall Survival in Advanced Classical Hodgkin Lymphoma - a Real World Analysis

Moussab Damlaj, MD, Mohsen Al-Zahrani, MD, Ghulam Syed, MD, Giamal Gmati, MD, Tabrez Pasha, Khadega Abuelgasim, MD, Bader Alahmari, MD, Ayman Alhejazi, MD, Ahmed Alaskar, MD FRCPC

Blood (2017) 130 (Supplement 1): 2799.

https://doi.org/10.1182/blood.V130.Suppl_1.2799.2799

Published: 2017

Journal Articles

Prognostic Impact of Blood Count Recovery Based Complete Remission Prior to Allogeneic Transplantation in Patients with Acute Leukemia

Moussab Damlaj, MD, Ghazi Samer, Giamal Edin Mohamed Gmati, MD, Walid Mashaqbeh, Mohsen Al Zahrani, MD, Khadega Ahmed Abuelgasim, MD, Mushtaq Rather, MD, Hend Salama, MD, Ahmed Askar, MD, Ayman Hejazi, MD

Blood (2016) 128 (22): 5787.

https://doi.org/10.1182/blood.V128.22.5787.5787

Published: 2016

Journal Articles

Role of FDG-PET/CT for Detection of Occult Bone Marrow Involvement in Patients from the Middle East and North Africa Region with Hodgkin Lymphoma

Moussab Damlaj, MD, Giamal Edin Mohamed Gmati, MD, Ghulam Syed, MD, Mohsen Al Zahrani, MD, Khadega Ahmed Abuelgasim, MD, Mushtaq Rather, MD, Salama Hend, MD, Hejazi Ayman, MD, Abdul-Rahman Jazieh, MD, Ahmed Askar, MD

Blood (2016) 128 (22): 5348.

https://doi.org/10.1182/blood.V128.22.5348.5348

Published: 2016

Journal Articles

The Hybrid Regimen of ABVD/BEACOPP May Overcome the High-Risk Features of the Advanced Stage Hodgkin Lymphoma

Ahmed Alaskar, MD, Ahmad Al Ameer, Gasmelseed Ahmed, MD, Ayman Alhejazi, MD, Khadega Abuelgasim, MD, Giamal Gmati, MD, Mushtaq Rather, MD, Mohsen Al Zahrani, MD

Blood (2014) 124 (21): 5477.

https://doi.org/10.1182/blood.V124.21.5477.5477

Published: 2014

NARROW

Multicenter, Real-World Experience Study of FLT3-Inhibitor Post-Transplant Maintenance Therapy Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia with FLT3-ITD

Comparison of Riete and Some Scores for Predicting Cancer in Unprovoked Thrombosis

Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy?

Allogeneic Transplantation for Sickle Cell Disease Offers High Rates of Cure with Low Incidence of Severe Chronic GVHD in Both Children and Adults: Real World Data from 2010-2021. An Analysis of the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Working Party

A Novel Score for Prediction of Cancer in Unprovoked Venous Thromboembolism

Significant Growth in HCT Use for Haemoglobinopathies in the Last Decade Driven By Sickle Cell Disease across All Ages with Excellent Outcomes: An Analysis of EBMT Haemoglobinopathies Working Party

Role of Age and Donor Type in 3646 Severe Aplastic Anemia Patients Undergoing Hematopoietic Stem Cell Transplantation in 2011-2020: A Retrospective EBMT-Saawp Study

Multicenter Retrospective Analysis on the Clinical Benefit of Post-Transplant Tyrosine Kinase Inhibitor (TKI) Maintenance Therapy in Ph-Positive Acute Lymphoblastic Leukemia Suggests Improved GvHD-Free, Relapse Free Survival and Non-Relapse Mortality, but Not the Risk of Relapse

Non-Myeloablative Transplant in Severe Sickle Cell Disease Is Safe & Effective. Single Center Experience from Saudi Arabia

Escalation from ABVD Following Positive Interim Functional Imaging Improves Progression Free Survival but Not Overall Survival in Advanced Classical Hodgkin Lymphoma - a Real World Analysis

Prognostic Impact of Blood Count Recovery Based Complete Remission Prior to Allogeneic Transplantation in Patients with Acute Leukemia

Role of FDG-PET/CT for Detection of Occult Bone Marrow Involvement in Patients from the Middle East and North Africa Region with Hodgkin Lymphoma

The Hybrid Regimen of ABVD/BEACOPP May Overcome the High-Risk Features of the Advanced Stage Hodgkin Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only